DVS Sciences Appoints Joseph Victor as President and CEO

December 5, 2011

SUNNYVALE, Calif. & TORONTO--DVS Sciences, Inc., a privately held innovator and manufacturer of novel CyTOF® multi-parameter single-cell analyzers and MAXPAR® reagents for biological research and potential clinical applications, today announced that Joseph Victor has been appointed President and CEO and a Director. Mr. Victor has more than 25 years of experience fostering product innovation and building value for customers, shareholders, and employees. Most recently, Mr. Victor was President and CEO of Applied Precision Inc. which was recently acquired by GE Healthcare. Before that he drove significant sales growth, new product development and overall profitability of the Applied Precision business in the roles of President, Sr. VP Life Sciences, VP R&D and Operations, and VP R&D. Prior to Applied Precision, Mr. Victor held various executive management and technical positions in the aviation, high technology, and energy markets.

Mr. Victor will assume the role of President and CEO from Dr. Scott Tanner, co-founder of DVS Sciences. “Our Board and I are delighted to welcome Joe to DVS Sciences and believe he is the ideal person to lead the company through its next phase of growth and expansion in the Life Sciences markets,” said Dr. Tanner. With Mr. Victor’s appointment, Dr. Tanner has transitioned to the role of Chief Technology Officer and General Manager of the company’s Canadian operations providing additional focus on the research and development of the mass cytometry technology platform at DVS Sciences.

Commenting on his appointment, Mr. Victor said, “This is a truly exciting opportunity. The CyTOF mass cytometry platform clearly holds tremendous promise in enabling scientists to better understand the cellular dynamics of disease states, stem cells and other biologically relevant systems. I look forward to working with the board of directors and the DVS Sciences’ team to accelerate the company’s growth and success.”

Mr. Victor will be located in the DVS Sciences global headquarters in Sunnyvale, California. He holds an MBA from UCLA and MS and BS degrees in engineering from the University of Washington.

For more information about DVS Sciences and the CyTOF mass cytometry platform, please visit www.DVSsciences.com

About DVS Sciences, Inc.
DVS Sciences, Inc. manufactures and globally distributes novel bioanalytical solutions for use in biomarker discovery, biological research and potential future use in clinical applications. The patented multi-parameter technology comprises a high-throughput mass cytometer for quantitative individual cell analysis, CyTOF, and a suite of MAXPAR reagents, which include stable-isotope-tagged antibodies. The CyTOF – MAXPAR system overcomes the limitations of conventional flow cytometry, simplifies sample preparation and can simultaneously identify up to 100 biomarkers with high resolution and wide dynamic range. CyTOF systems are installed in leading laboratories across the U.S., Canada, Europe and Asia.

DVS Sciences has an R&D and instrument manufacturing facility near Toronto, Canada, and its global headquarters and reagent kit manufacturing is located in Sunnyvale, California.